1. Home
  2. OCSAW

OCSAW

Oculis Holding AG Warrants

Logo Oculis Holding AG Warrants

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 2:50pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
-
.
-
-
%

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Founded: N/A Country:
Switzerland
Switzerland
Employees: 36 City: N/A
Market Cap: N/A IPO Year: N/A
Target Price: N/A AVG Volume (30 days): N/A
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: N/A Next Earning Date: N/A
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: